Consun Pharma repurchases 90,000 shares; treasury stock rises to 2.28 million

Bulletin Express06-25

Consun Pharmaceutical Group Limited reported to the Hong Kong Stock Exchange that it repurchased 90,000 ordinary shares on 25 June 2026. The shares were bought on-market at prices ranging from HK$12.81 to HK$12.85, with a volume-weighted average of HK$12.83, for a total consideration of approximately HK$1.16 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) decreased from 839.36 million to 839.27 million shares. Treasury shares increased to 2.28 million, while the total number of issued shares remained unchanged at 841.55 million. The latest buyback represents 0.0107% of the company’s outstanding shares before the purchase.

The repurchase forms part of the mandate approved on 26 May 2026, which permits Consun Pharma to buy back up to 84.12 million shares. Cumulative repurchases under this mandate now stand at 1.94 million shares, equivalent to 2.30% of the company’s issued shares on the mandate date.

In accordance with Main Board Rule 10.06, the company is restricted from issuing new shares or disposing of treasury shares until 25 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145596584?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145596584","market":"us","top_or_hot":-1,"title":"Consun Pharma repurchases 90,000 shares; treasury stock rises to 2.28 million","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited reported to the Hong Kong Stock Exchange that it repurchased 90,000 ordinary shares on 25 June 2026. The shares were bought on-market at prices ranging from HK$12.81 to HK$12.85, with a volume-weighted average of HK$12.83, for a total consideration of approximately HK$1.16 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) decreased from 839.36 million to 839.27 million shares. Treasury shares increased to 2.28 million, while the total number of issued shares remained unchanged at 841.55 million. The latest buyback represents 0.0107% of the company’s outstanding shares before the purchase.</p>\n<p>The repurchase forms part of the mandate approved on 26 May 2026, which permits Consun Pharma to buy back up to 84.12 million shares. Cumulative repurchases under this mandate now stand at 1.94 million shares, equivalent to 2.30% of the company’s issued shares on the mandate date.</p>\n<p>In accordance with Main Board Rule 10.06, the company is restricted from issuing new shares or disposing of treasury shares until 25 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharma repurchases 90,000 shares; treasury stock rises to 2.28 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharma repurchases 90,000 shares; treasury stock rises to 2.28 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-25 20:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited reported to the Hong Kong Stock Exchange that it repurchased 90,000 ordinary shares on 25 June 2026. The shares were bought on-market at prices ranging from HK$12.81 to HK$12.85, with a volume-weighted average of HK$12.83, for a total consideration of approximately HK$1.16 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) decreased from 839.36 million to 839.27 million shares. Treasury shares increased to 2.28 million, while the total number of issued shares remained unchanged at 841.55 million. The latest buyback represents 0.0107% of the company’s outstanding shares before the purchase.</p>\n<p>The repurchase forms part of the mandate approved on 26 May 2026, which permits Consun Pharma to buy back up to 84.12 million shares. Cumulative repurchases under this mandate now stand at 1.94 million shares, equivalent to 2.30% of the company’s issued shares on the mandate date.</p>\n<p>In accordance with Main Board Rule 10.06, the company is restricted from issuing new shares or disposing of treasury shares until 25 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1145596584","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145596584","pubTimestamp":1782390270,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited reported to the Hong Kong Stock Exchange that it repurchased 90,000 ordinary shares on 25 June 2026. The shares were bought on-market at prices ranging from...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业回购9万股；库存股升至228万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited reported to the Hong Kong Stock Exchange that it repurchased 90,000 ordinary shares on 25 June 2026. The shares were bought on-market at prices ranging from HK$12.81 to HK$12.85, with a volume-weighted average of HK$12.83, for a total consideration of approximately HK$1.16 million.\nFollowing the transaction, the company’s issued share capital (excluding treasury shares) decreased from 839.36 million to 839.27 million shares. Treasury shares increased to 2.28 million, while the total number of issued shares remained unchanged at 841.55 million. The latest buyback represents 0.0107% of the company’s outstanding shares before the purchase.\nThe repurchase forms part of the mandate approved on 26 May 2026, which permits Consun Pharma to buy back up to 84.12 million shares. Cumulative repurchases under this mandate now stand at 1.94 million shares, equivalent to 2.30% of the company’s issued shares on the mandate date.\nIn accordance with Main Board Rule 10.06, the company is restricted from issuing new shares or disposing of treasury shares until 25 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145596584","isCrawlerRequest":true}